ea0035p172 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014
Saklamaz Ali
, Uyar Belkis
, Solak Aynur
, Akyildiz Muhittin
, Genc Berhan
, Gokduman Ayse
, Yalcin Murat
, Aykir Halil
, Kirgiz Ozlem Ozenturk
Introduction: Isotretinoin (Iso) treatment in acne disease may cause dyslipidemia and increased liver enzymes. Its effects on lipid and glucose metabolism may cause atherogenic complications. The aim of this study was to evaluate carotis intima–media thickness (CIMT), HOMA-IR, and osteopontin (OPN) levels in acne patients on Iso treatment.Methods: Iso treatment given 21 patients are included in this study. They followed for 4 months. 21 patients wit...